Empagliflozin reduces blood pressure and uric acid in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Empagliflozin reduces blood pressure and uric acid in patients with type 2 diabetes mellitus: a systematic review and meta-analysisEmpagliflozin reduces blood pressure and uric acid in patients with type 2 diabetes mellitus: a systematic review and meta-analysis, Published online: 15 November 2018; doi:10.1038/s41371-018-0134-2Empagliflozin reduces blood pressure and uric acid in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Source: Journal of Human Hypertension - November 15, 2018 Category: Cardiology Authors: Di Zhao Hui Liu Pingshuan Dong Source Type: research